- Report
- November 2023
- 154 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- November 2023
- 161 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- November 2023
- 151 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- October 2023
- 164 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- September 2022
- 120 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- January 2022
- 120 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- January 2022
- 120 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- January 2022
- 120 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- November 2021
- 120 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- March 2026
- 208 Pages
Japan
From €2258EUR$2,500USD£1,960GBP
- Report
- June 2025
- 215 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- June 2025
- 197 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- June 2025
- 209 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- June 2025
- 206 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- June 2025
- 228 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- June 2025
- 215 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- June 2025
- 210 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- June 2025
- 219 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- June 2025
- 201 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- May 2025
- 205 Pages
Global
From €2258EUR$2,500USD£1,960GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more